These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29146245)

  • 1. Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells.
    Joris F; De Backer L; Van de Vyver T; Bastiancich C; De Smedt SC; Raemdonck K
    J Control Release; 2018 Jan; 269():266-276. PubMed ID: 29146245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner.
    Van de Vyver T; Bogaert B; De Backer L; Joris F; Guagliardo R; Van Hoeck J; Merckx P; Van Calenbergh S; Ramishetti S; Peer D; Remaut K; De Smedt SC; Raemdonck K
    ACS Nano; 2020 Apr; 14(4):4774-4791. PubMed ID: 32250113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating β
    Merckx P; Conickx G; Blomme E; Maes T; Bracke KR; Brusselle G; De Smedt SC; Raemdonck K
    Eur J Pharm Biopharm; 2024 Apr; 197():114223. PubMed ID: 38367760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments.
    Van de Vyver T; Muntean C; Efimova I; Krysko DV; De Backer L; De Smedt SC; Raemdonck K
    J Control Release; 2023 Dec; 364():142-158. PubMed ID: 37816483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
    Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
    J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing Angiogenesis Factors in Hypoxic Diabetic Wound Conditions by siRNA Delivery: Additive Effect of LbL-Gold Nanocarriers and Desloratadine-Induced Lysosomal Escape.
    Shaabani E; Sharifiaghdam M; Lammens J; De Keersmaecker H; Vervaet C; De Beer T; Motevaseli E; Ghahremani MH; Mansouri P; De Smedt S; Raemdonck K; Faridi-Majidi R; Braeckmans K; Fraire JC
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repositioning the antihistamine ebastine as an intracellular siRNA delivery enhancer.
    Muntean C; Blondeel E; Harinck L; Pednekar K; Prakash J; De Wever O; Chain JL; De Smedt SC; Remaut K; Raemdonck K
    Int J Pharm; 2023 Sep; 644():123348. PubMed ID: 37633539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged gene silencing by combining siRNA nanogels and photochemical internalization.
    Raemdonck K; Naeye B; Høgset A; Demeester J; De Smedt SC
    J Control Release; 2010 Aug; 145(3):281-8. PubMed ID: 20403396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy.
    Li H; Yang X; Gao F; Qian C; Li C; Oupicky D; Sun M
    J Control Release; 2018 Dec; 292():78-90. PubMed ID: 29499219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visible light-switched cytosol release of siRNA by amphiphilic fullerene derivative to enhance RNAi efficacy in vitro and in vivo.
    Wang J; Xie L; Wang T; Wu F; Meng J; Liu J; Xu H
    Acta Biomater; 2017 Sep; 59():158-169. PubMed ID: 28511875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
    Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
    J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoactivation of sulfonated polyplexes enables localized gene silencing by DsiRNA in breast cancer cells.
    Puri A; Viard M; Zakrevsky P; Zampino S; Chen A; Isemann C; Alvi S; Clogston J; Chitgupi U; Lovell JF; Shapiro BA
    Nanomedicine; 2020 Jun; 26():102176. PubMed ID: 32151748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line.
    Ben Djemaa S; Hervé-Aubert K; Lajoie L; Falanga A; Galdiero S; Nedellec S; Soucé M; Munnier E; Chourpa I; David S; Allard-Vannier E
    Biomacromolecules; 2019 Aug; 20(8):3076-3086. PubMed ID: 31305991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy.
    Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X
    Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery.
    Chen CJ; Wang JC; Zhao EY; Gao LY; Feng Q; Liu XY; Zhao ZX; Ma XF; Hou WJ; Zhang LR; Lu WL; Zhang Q
    Biomaterials; 2013 Jul; 34(21):5303-16. PubMed ID: 23570718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 2-responsive micelle for siRNA delivery.
    Wang HX; Yang XZ; Sun CY; Mao CQ; Zhu YH; Wang J
    Biomaterials; 2014 Aug; 35(26):7622-34. PubMed ID: 24929619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.